RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact

about

RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact

Item

http://www.wikidata.org/entity/Q58704356

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

RKIP: A Key Regulator in Tumor ...... erapeutic Targeting and Impact

@en

RKIP: A Key Regulator in Tumor ...... erapeutic Targeting and Impact

@nl

type

Item

label

RKIP: A Key Regulator in Tumor ...... erapeutic Targeting and Impact

@en

RKIP: A Key Regulator in Tumor ...... erapeutic Targeting and Impact

@nl

prefLabel

RKIP: A Key Regulator in Tumor ...... erapeutic Targeting and Impact

@en

RKIP: A Key Regulator in Tumor ...... erapeutic Targeting and Impact

@nl

P1476

RKIP: A Key Regulator in Tumor ...... erapeutic Targeting and Impact

@en

P2093

Benjamin Bonavida

http://www.w3.org/2001/XMLSchema#string

Ekaterini Chatzaki

http://www.w3.org/2001/XMLSchema#string

Stavroula Baritaki

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion

Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation

Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression

The biological complexity of RKIP signaling in human cancers

Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics

P304

287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS10090287

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Apostolos Zaravinos

P577

2018-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30149591

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6162400

http://www.w3.org/2001/XMLSchema#string